New Nexus Pharmacêutica Factory in Sorocaba Will Create 300 Jobs, Produce Ozempic Generic and Strengthen the Pharmaceutical Sector.
The City Hall of Sorocaba (SP) made an important announcement regarding the installation of a new factory in the city’s Technology Park. The new unit will be operated by Nexus Pharmacêutica, a pharmaceutical industry formed by the merger of three companies: LCA Farmacêutica, Stanley’s Holding, and Unikka Pharma.
Factory Construction and Investments
The new factory will occupy an initial area of 2,000 square meters in the Technology Park, with an initial investment of R$ 20 million.
The total construction of the unit is expected to be completed in up to 24 months, with an additional investment of R$ 40 million, expanding the area to 6,000 square meters.
-
Historic bankruptcy of Centauro shocks the market, and the century-old company puts more than 500,000 products, machines, and complete infrastructure up for online auction.
-
New shoe factory in Ceará is expected to create 400 jobs and strengthen the local economy.
-
No one imagined it, but a mixture of sawdust with a mineral that fights fires surprises scientists with a result that changes the course of fire-resistant construction.
-
From empty land to a high-end house, wooden construction uses a lightweight system, metal structure for the foundation, ventilated ceramic cladding, and special windows to create an efficient and comfortable living space throughout the year.
Construction is set to begin later this year, with the technical project already completed, as informed by Lucas Gasparini, a partner at LCA Farmacêutica.
The installation of the new pharmaceutical industry is expected to create approximately 300 direct and indirect jobs. To meet the demand for new professionals, the Sorocaba city hall intends to offer vocational courses.
This aims to prepare workers for the various areas needed in the factory and ensure that the local population benefits from the new job opportunities.
Production of Ozempic Generic and Other Medications
One of the main products of the new factory will be the Ozempic generic, a medication currently manufactured by the Danish company Novo Nordisk, which holds the patent until 2026.
After the patent exclusivity ends, Nexus Pharmacêutica will begin producing the generic, with an expected average price of R$ 400.
In addition to Ozempic, the pharmaceutical industry plans to manufacture around 250 medications, including dipyrone, antidepressants, antibiotics, and creams.
These medications will be distributed to both the Unified Health System (SUS) and pharmacy networks. The factory will not only produce the medications but will also handle their sale and distribution from Sorocaba.
Impact on the Local and Regional Economy
The arrival of Nexus Pharmacêutica in Sorocaba represents a significant economic boost for the region.
With the construction of the new factory, the city not only benefits from job creation but also positions itself as an important hub in the pharmaceutical sector.
This development may attract other investments and companies to the Technology Park, promoting an environment of innovation and economic growth.
Furthermore, the ongoing investment in the expansion of the factory demonstrates the company’s commitment to the expansion and strengthening of the local economy.
The production of the Ozempic generic and the offering of a wide range of medications aim to improve access to healthcare for the population.
By providing essential medications at more affordable prices, the new factory will contribute to strengthening the Unified Health System (SUS) and help meet the needs of various social groups.
The presence of Nexus Pharmacêutica in Sorocaba reinforces the importance of having a robust pharmaceutical industry committed to public health and accessibility to treatments.
Partnerships and Community Collaboration at the Factory
In addition to the economic and social benefits, the establishment of Nexus Pharmacêutica in Sorocaba also opens up opportunities for partnerships and collaborations with local and regional institutions.
The company intends to work together with universities and research centers to promote innovations in the pharmaceutical field and develop new products.
This type of collaboration can create research and development opportunities, as well as foster education and technological advancement in the region.
The integration with the local academic and scientific community will not only strengthen the factory’s innovation capacity but also contribute to the development of the pharmaceutical sector as a whole.

Bom dia! Para onde enviar o currículo para se candidatar?
Obrigada
Como faz pra encaminhar currículo